Research Progress in Management of IgA Nephropathy / 沈阳医学院学报

ABSTRACT

Immunoglobulin A nephropathy (IgAN) is the most common type of glomerulonephritis in the world and causes end-stage renal disease (ESRD), So there is a need for effective treatment strategies to prevent the decline in kidney function. Traditional treatment is based on blood pressure control, angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), corticosteroid and immunosuppressive. In recent years, along with a better understangding of its pathogenesis, the new treatment has been put forward.